Risk Stratification Before and During Treatment in Newly Diagnosed Multiple Myeloma: From Clinical Trials to the Real-World Setting

Multiple Myeloma (MM) is a hematologic malignancy characterized by a wide clinical and biological heterogeneity leading to different patient outcomes. Various prognostic tools to stratify newly diagnosed (ND)MM patients into different risk groups have been proposed. At baseline, the standard-of-care...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonello, Francesca, Cani, Lorenzo, D’Agostino, Mattia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959380/
https://www.ncbi.nlm.nih.gov/pubmed/35356221
http://dx.doi.org/10.3389/fonc.2022.830922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959380/
https://www.ncbi.nlm.nih.gov/pubmed/35356221
http://dx.doi.org/10.3389/fonc.2022.830922

Ejemplares similares